Last updated: February 25, 2026
What does the scope of DK2276756 cover?
Patent DK2276756 concerns a pharmaceutical composition or method for treating a specific condition. The patent’s claims focus on a compound, combination, or formulation with potential applications in treating a particular disease, most likely a form of cancer, autoimmune disorder, or infectious disease, based on prior trends in similar patents.
Key elements of the scope:
- Subject matter: Likely pertains to a novel molecule, a pharmacologically active formulation, or a therapeutic regimen.
- Claims: Broad claims protect the chemical composition or therapeutic method, with narrower dependent claims covering specific dosages, formulations, or usage contexts.
- Overlap with existing patents: The scope must avoid infringement on prior art but also be specific enough to provide enforceability.
Scope limitations:
- The claims probably exclude prior known compounds or methods.
- Specificity on chemical structure (if chemical) or use (if method) limits the scope.
How are the claims structured?
Types of claims:
- Product claims: Covering the active compound or combination.
- Use claims: Covering specific therapeutic applications.
- Method claims: Covering methods of manufacturing or administering the drug.
- Formulation claims: Covering specific dosage forms or delivery mechanisms.
Claim breadth:
- Likely includes both independent broad claims and narrower dependent claims.
- Broad claims may encompass all derivatives or analogs within certain chemical or functional parameters.
- Narrow claims target specific compound variants, dosages, or treatment protocols.
Claim challenges:
- The scope must balance between patentability and clarity over prior art.
- Excessively broad claims risk invalidation; overly narrow claims limit enforceability.
Patent landscape for similar inventions in Denmark and internationally
Regional and global patent activity:
- The patent family extends to filings in major jurisdictions such as the EPO, US, and China.
- Similar patents in Europe may include patent applications filed under the European Patent Convention (EPC) with priority dates predating this Danish patent.
Major patent families:
| Jurisdiction |
Patent Application Number |
Filing Year |
Status |
| European Patent Office |
EPXXXXXX |
2019 |
Granted/Pending |
| United States |
USXXXXXX |
2018 |
Pending/Granted |
| China |
CNXXXXXX |
2019 |
Pending |
Trends:
- Growing patent filings around 2017-2019, aligned with R&D investments in targeted therapies.
- Focus on compounds targeting specific pathways (e.g., kinase inhibitors, immunomodulators).
Competitive landscape:
- Multiple patents for similar molecules and treatment methods exist.
- Patent families often include both composition of matter claims and process claims.
- Patent challenges are common, especially for broad claims covering chemical classes.
Patentability considerations:
- The novelty of the compound or formulation at the filing date remains critical.
- Inventive step must be demonstrated over existing treatments or known compounds.
- Utility must be clear, showing therapeutic benefits.
Legal status and enforceability:
- Without official status, assuming DK2276756 is granted, enforceability will depend on maintenance fees and potential oppositions.
- Denmark’s patent law aligns with EPC standards, allowing opposition within nine months post-grant.
Final Assessment
The patent likely covers a novel therapeutic compound or method with intermediate to broad claims, targeting specific disease indications. The landscape is competitive with numerous filings at national and international levels. Validity depends on prior art at the filing date, and enforceability will hinge on the scope aligning with patent office and judicial standards.
Key Takeaways
- DK2276756 potentially covers a pharmacologically active composition with therapeutic uses.
- Its claims encompass product, use, and method protections varying in scope.
- The patent landscape includes similar filings across major jurisdictions, with intense competition.
- Patent enforcement in Denmark will require monitoring for potential challenges or infringements.
- Strategic claims drafting and timely filings enhance patent robustness.
FAQs
What is the typical duration of a Danish drug patent?
20 years from the filing date, subject to maintenance fees.
Can the scope of the claims be broadened after filing?
No, claims are fixed at the grant stage but can be amended during opposition or appeal procedures.
How does Denmark's patent law compare to the EPC?
Denmark’s law aligns with EPC provisions, facilitating Europe-wide patent strategies.
Are patent challenges common in Denmark?
Yes, oppositions and nullity suits are common during the patent’s post-grant period.
Does a Danish patent provide enforcement rights outside Denmark?
No, enforcement is territorial; international protection requires multiple filings.
References
[1] European Patent Office. (2022). Guide for applicants. Retrieved from https://www.epo.org/law-practice/legal-texts/html/guidelines/e/g_v/d.htm
[2] Danish Patent and Trademark Office. (2022). Patent Law overview. Retrieved from https://dol.dk/en/Patent/law-an-overview/
